JP2005501061A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005501061A5 JP2005501061A5 JP2003518452A JP2003518452A JP2005501061A5 JP 2005501061 A5 JP2005501061 A5 JP 2005501061A5 JP 2003518452 A JP2003518452 A JP 2003518452A JP 2003518452 A JP2003518452 A JP 2003518452A JP 2005501061 A5 JP2005501061 A5 JP 2005501061A5
- Authority
- JP
- Japan
- Prior art keywords
- nutritional supplement
- sod
- group
- support component
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015872 dietary supplement Nutrition 0.000 claims 15
- 102000019197 Superoxide Dismutase Human genes 0.000 claims 10
- 108010012715 Superoxide dismutase Proteins 0.000 claims 10
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 6
- 230000002438 mitochondrial effect Effects 0.000 claims 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 3
- 235000017471 coenzyme Q10 Nutrition 0.000 claims 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims 3
- 229940110767 coenzyme Q10 Drugs 0.000 claims 3
- 210000003205 muscle Anatomy 0.000 claims 3
- 229960003104 ornithine Drugs 0.000 claims 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N ornithyl group Chemical group N[C@@H](CCCN)C(=O)O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- 108010061711 Gliadin Proteins 0.000 claims 2
- 208000017580 chronic wasting disease Diseases 0.000 claims 2
- 230000036542 oxidative stress Effects 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- SLPUVFBNQHVEEU-WCCKRBBISA-N (2s)-2,5-diaminopentanoic acid;2-oxopentanedioic acid Chemical compound NCCC[C@H](N)C(O)=O.OC(=O)CCC(=O)C(O)=O SLPUVFBNQHVEEU-WCCKRBBISA-N 0.000 claims 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims 1
- 229920002498 Beta-glucan Polymers 0.000 claims 1
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 150000005693 branched-chain amino acids Chemical class 0.000 claims 1
- 239000005018 casein Substances 0.000 claims 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims 1
- 235000021240 caseins Nutrition 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 210000003470 mitochondria Anatomy 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 229940075858 ornithine alpha-ketoglutarate Drugs 0.000 claims 1
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 1
- 235000013824 polyphenols Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000003313 weakening effect Effects 0.000 claims 1
- 235000021119 whey protein Nutrition 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/927,174 US6503506B1 (en) | 2001-08-10 | 2001-08-10 | Nutrient therapy for immuno-compromised patients |
| PCT/US2002/025358 WO2003013438A2 (en) | 2001-08-10 | 2002-08-09 | Nutrient therapy for immuno-compromised patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005501061A JP2005501061A (ja) | 2005-01-13 |
| JP2005501061A5 true JP2005501061A5 (enExample) | 2006-01-05 |
Family
ID=25454328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003518452A Pending JP2005501061A (ja) | 2001-08-10 | 2002-08-09 | 免疫機能損傷患者の為の栄養療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6503506B1 (enExample) |
| EP (1) | EP1432436A4 (enExample) |
| JP (1) | JP2005501061A (enExample) |
| CN (1) | CN1568196A (enExample) |
| AP (1) | AP2004002994A0 (enExample) |
| CA (1) | CA2457624A1 (enExample) |
| EA (1) | EA006439B1 (enExample) |
| OA (1) | OA12649A (enExample) |
| WO (1) | WO2003013438A2 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6616942B1 (en) | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
| FR2822704B1 (fr) * | 2001-03-29 | 2005-02-18 | Chiesi Sa | Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments |
| US6503506B1 (en) * | 2001-08-10 | 2003-01-07 | Millenium Biotechnologies, Inc. | Nutrient therapy for immuno-compromised patients |
| US20080089877A1 (en) * | 2003-08-14 | 2008-04-17 | Udell Ronald G | Super Absorption Coenzyme Q10 |
| US7169385B2 (en) * | 2003-09-29 | 2007-01-30 | Ronald G. Udell | Solubilized CoQ-10 and carnitine |
| US8124072B2 (en) | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
| AU2004277951B2 (en) | 2003-09-29 | 2010-11-11 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
| ITTO20030789A1 (it) | 2003-10-07 | 2005-04-08 | Professional Dietetics Srl | Composizione a base di amino acidi per il trattamento |
| EP1675480B1 (en) * | 2003-10-16 | 2018-06-13 | Nestec S.A. | Nutritional composition against side effects of chemotherapy of radiotherapy |
| EP1718283B1 (en) | 2004-01-22 | 2013-03-06 | University of Miami | Topical co-enzyme q10 formulations and methods of use |
| JP2007519678A (ja) * | 2004-01-28 | 2007-07-19 | ネステク ソシエテ アノニム | 皮膚状態を改良しそして皮膚病を予防するための栄養組成物 |
| US20050209170A1 (en) * | 2004-03-18 | 2005-09-22 | Takemoto Arnold C | Breast health preparations |
| AU2005223618A1 (en) * | 2004-03-17 | 2005-09-29 | Arnold C. Takemoto | Tissue detoxification and health supplements and methods of making and using them |
| JP2005336176A (ja) * | 2004-04-28 | 2005-12-08 | Tanabe Seiyaku Co Ltd | 肉体疲労改善剤 |
| EP1600061B1 (en) * | 2004-05-25 | 2010-05-12 | Cognis IP Management GmbH | Oral and/or topical compositions |
| US20050265990A1 (en) * | 2004-06-01 | 2005-12-01 | Shawn Talbott | Treatments and nutritional supplements for assisting post-exercise recovery |
| NZ552908A (en) * | 2004-06-30 | 2009-11-27 | Atsuo Sekiyama | Indicator agent for noninflammatory stress response and use thereof |
| KR100584891B1 (ko) | 2004-08-13 | 2006-05-30 | (주)씨스팜 | 경구용 슈퍼옥사이드 디스뮤타제 제제인, 캔털루프 멜론추출물과 글리아딘 결합물을 숙취해소에 사용하는 방법 |
| US7284385B2 (en) * | 2004-09-16 | 2007-10-23 | Hess Spencer W | Pre-dried air reactivation for diesel fuel heated dessicant reactivator |
| JP5040060B2 (ja) * | 2004-10-14 | 2012-10-03 | 大正製薬株式会社 | メチオニン配合内服液剤 |
| US20060147550A1 (en) * | 2004-12-30 | 2006-07-06 | Gorsek Wayne F | Immune system enhancement and stimulation formulation |
| WO2008136793A1 (en) | 2007-05-03 | 2008-11-13 | Williams Christopher P | Low radiocarbon dietary supplements and methods of making same |
| US20070114476A1 (en) * | 2005-11-04 | 2007-05-24 | Williams Christopher P | Low radiocarbon nucleotide and amino acid dietary supplements |
| CN101316582A (zh) * | 2005-11-30 | 2008-12-03 | 雀巢技术公司 | 治疗肌肉损失的方法 |
| WO2007077995A1 (ja) * | 2006-01-05 | 2007-07-12 | Kyowa Hakko Kogyo Co., Ltd. | 筋肉増量剤 |
| GB0603975D0 (en) * | 2006-03-01 | 2006-04-05 | Etren | Methods and agents for reducing oxidative stress |
| CA2645674A1 (en) * | 2006-03-15 | 2007-09-20 | Isocell Pharma S.A. | Pharmaceutical compositions comprising sods and prolamine based peptide fragments |
| FR2899065B1 (fr) * | 2006-03-29 | 2008-07-18 | Alain Dreyer Brevets Et Dev So | Sod micro encapsulee et adsorbee sur support mineral et vegetal destinee a l'alimentation animale |
| DE102006046960A1 (de) * | 2006-10-04 | 2008-04-10 | Euro Allianz Pharma Gmbh | Gesundheitsfördernde Nahrungsmittelzusammensetzung |
| US20080119386A1 (en) * | 2006-11-22 | 2008-05-22 | Carl Germano | Nutritional formula for athletes' recovery |
| US8343541B2 (en) | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
| CN102309503B (zh) * | 2007-09-27 | 2013-11-20 | 生物高聚物工程公司Dba生物治疗公司 | β-葡聚糖用于上呼吸道感染症状和心理健康 |
| WO2009099444A1 (en) * | 2008-02-08 | 2009-08-13 | Millennium Biotechnologies, Inc. | Nutritional formula for athletes' recovery |
| WO2009126764A1 (en) | 2008-04-11 | 2009-10-15 | Cytotech Labs, Llc | Methods and use of inducing apoptosis in cancer cells |
| US8865733B2 (en) * | 2008-11-06 | 2014-10-21 | Altman Enterprises, LLC | Medication and treatment for disease |
| CN102482713B (zh) | 2009-05-11 | 2017-06-30 | 博格有限责任公司 | 利用表观代谢转变剂、多维细胞内分子或环境影响剂诊断肿瘤障碍的方法 |
| EP2311449A1 (de) * | 2009-10-14 | 2011-04-20 | NÖM Aktiengesellschaft | Oral verabreichbare nahrungsergänzende Zusammensetzung enthaltend Carnitin |
| DK3372228T3 (da) * | 2010-12-23 | 2025-05-26 | Amazentis Sa | Ikke-terapeutisk fremgangsmåde til at øge eller opretholde mitokondriefunktion |
| WO2012097061A1 (en) * | 2011-01-13 | 2012-07-19 | Abbott Laboratories | Nutritional compositions and methods for improving skeletal muscle protein metabolism |
| WO2012099980A2 (en) * | 2011-01-18 | 2012-07-26 | Equine Nutriceuticals, Llc | Equine nutritional supplement |
| WO2012138765A1 (en) | 2011-04-04 | 2012-10-11 | Berg Pharma Llc | Methods of treating central nervous system tumors |
| EA032775B1 (ru) | 2013-04-08 | 2019-07-31 | Берг Ллк | Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10 |
| EP3041496B1 (en) | 2013-09-04 | 2020-04-29 | Berg LLC | Methods of treatment of cancer by continuous infusion of coenzyme q10 |
| US20170189350A1 (en) | 2015-11-16 | 2017-07-06 | Berg Llc | Methods of treatment of temozolomide-resistant glioma using coenzyme q10 |
| CN105709212A (zh) * | 2016-01-29 | 2016-06-29 | 周瑞华 | 一种免疫平衡调节剂及其制备方法和应用 |
| RU2656544C1 (ru) * | 2017-07-07 | 2018-06-05 | Общество с ограниченной ответственностью "Академия-Т" | Функциональный продукт питания для коррекции психофизиологического состояния и нейромышечной передачи у спортсменов |
| WO2020033874A1 (en) * | 2018-08-10 | 2020-02-13 | Maine Natural Health Company, Inc. | Comestible compositions for promoting atp synthesis |
| CN110664824B (zh) * | 2019-08-09 | 2021-01-01 | 北京佳博泰和健康科技有限公司 | 一种营养支持剂及其制备方法和用途 |
| CN111820330A (zh) * | 2020-07-17 | 2020-10-27 | 禹城保立康生物饲料有限公司 | 一种提高哺乳仔猪发育的母猪饲料 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5456924A (en) * | 1988-12-23 | 1995-10-10 | Immunotec Research Corporation Ltd. | Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| IT1258491B (it) * | 1992-09-24 | 1996-02-26 | Sigma Tau Ind Farmaceuti | Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi. |
| FR2729296B1 (fr) | 1995-01-12 | 1997-03-28 | Europlanaire | Compositions pharmaceutiques comprenant une superoxyde dismutase |
| US5817329A (en) * | 1997-02-28 | 1998-10-06 | Gardiner; Paul T. | Nutritional supplement for increased muscle size and strength for body builders |
| US6503506B1 (en) * | 2001-08-10 | 2003-01-07 | Millenium Biotechnologies, Inc. | Nutrient therapy for immuno-compromised patients |
-
2001
- 2001-08-10 US US09/927,174 patent/US6503506B1/en not_active Expired - Fee Related
-
2002
- 2002-08-09 WO PCT/US2002/025358 patent/WO2003013438A2/en not_active Ceased
- 2002-08-09 EP EP02759316A patent/EP1432436A4/en not_active Ceased
- 2002-08-09 JP JP2003518452A patent/JP2005501061A/ja active Pending
- 2002-08-09 OA OA1200400043A patent/OA12649A/en unknown
- 2002-08-09 AP APAP/P/2004/002994A patent/AP2004002994A0/en unknown
- 2002-08-09 EA EA200400291A patent/EA006439B1/ru not_active IP Right Cessation
- 2002-08-09 CN CNA028199790A patent/CN1568196A/zh active Pending
- 2002-08-09 CA CA002457624A patent/CA2457624A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005501061A5 (enExample) | ||
| RU2633071C2 (ru) | Препарат для применения аспартата и витамина в12 или биотина для регуляции кетоновых тел | |
| JP2006510711A5 (enExample) | ||
| ES2569922T3 (es) | Composiciones nutritivas, que incluyen un componente de alto contenido en proteínas y nucleótidos exógenos | |
| WO2003013438A3 (en) | Nutrient therapy for immuno-compromised patients | |
| US20040071825A1 (en) | Agglomerated granular protein-rich nutritional supplement | |
| US11412768B2 (en) | Method of improving tolerance to hypoallergenic infant formulas | |
| JP2007519678A (ja) | 皮膚状態を改良しそして皮膚病を予防するための栄養組成物 | |
| US9144592B2 (en) | Dietary supplement with protein activator | |
| JP2002065212A (ja) | 筋強化用食品組成物及び筋強化剤 | |
| Martínez Augustín et al. | Arginina, óxido nítrico y función endotelial | |
| Klatz | The Official Anti-Aging Revolution: Stop the Clock Time is on Your Side for a Younger, Stronger, Happier You | |
| AU2002358347B2 (en) | Modified methionine rich food products and process for their manufacture | |
| WO2022177516A1 (en) | Nutritional powder compositions for promoting wound healing | |
| WO2017146561A1 (es) | Suplemento dietético para mejorar la fijación de nutrimento e incrementar la masa muscular | |
| HK1146373B (en) | Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas |